English

A video summary of current scientific studies conducted by U.S. government agencies on mpox surveillance and population science. 

This webpage discusses how mpox (formerly known as monkeypox) is caused by a virus that is related to the virus that causes smallpox. JYNNEOS is a two-dose vaccine developed to protect against mpox and smallpox infections. People need to get both doses of the vaccine for the best protection against mpox. The second dose should be given four weeks after the first dose.

This online course was developed to help TB nurses and clinicians learn about TB laboratory testing best practices. Topics covered in the course include specimen preparation, detection, identification, drug susceptibility testing, and supplemental testing. The course includes resources, a glossary, and a job aid. 

This guide was developed by the National Coalition for Sexual Health (NCSH)’s Health Care Action Group to cultivate a clinical environment that supports health care providers and clinical staff in the delivery of inclusive sexual health services to all patients.

This infographic discusses how in 2018, injection drug use (IDU) was highest among men (21%),

The Syphilis and Drug User Health Webinar Series consists of five monthly sessions where those working on STIs – specifically syphilis – and those working in harm reduction or drug user health will be brought together to learn from each other, share promising practices, and highlight effective cross-sector partnerships.

This video discusses an overview of the new GHSS, the five strategic directions, and the 2025 and 2030 targets. 

The progress countries have made to these goals and what needs to be done to achieve them.   

How community-based organizations and activists can use the GHSS and its targets for advocacy and to hold countries and health systems accountable to their commitments.  

Good practice examples of using the previous GHSS for advocacy and how countries have used GHSS in the planning and implementation of their national programmes.  

This packet of recommendations discusses how in October 2022, INHSU Prisons and the Coalition for Global Hepatitis Elimination (CGHE), Task Force for Global Health convened a workshop on the strategies for expanding access to hepatitis C virus (HCV) prevention, testing, and treatment in prison settings. During the workshop, barriers and recommendations to accelerating HCV elimination in prison settings were examined in four areas: 1) Policy, 2) Implementation, 3) Financing, and 4) Awareness.

This webpage discusses how good oral health is an important part of managing HIV and your overall health. With the right treatment, your mouth can feel better. That is a big step toward living well with HIV.

This video is part of the NIDA series At the Intersection: Stories of Research, Compassion, and HIV Services for People who Use Drugs.“Harm reduction” is defined as interventions aimed to help people avoid the negative effects of drug use by meeting people where they are with kindness and respect. In this video, viewers hear from people who use drugs, people who are in recovery from drug use, and harm reduction professionals on what harm reduction is (and isn’t) in their own words.